Pharmaceutical sponsors and clinical research organizations (CROs) are working to increase patient recruitment and retention rates and to improve trial performance using patient-centric engagement strategies to elevate the patient experience....
The majority of cancers do not have known screening markers, so research is needed to be sure potential biomarkers are predictive of disease, reduce mortality, do not lead to unnecessary procedures or needless worry, and are cost-effective....
Health disparities and inequities among marginalized communities reflect the institutional structures that impede communities from accessing healthcare and clinical studies....
Innovation is led by visionaries who anticipate potential crises and adapt, as opposed to accepting chaos as the forced catalyst for change. Some of these visionaries are gifted women who may have once been underestimated and unrecognized for their talents....
The U.S. FDA announced 19 new grants and two new contracts totaling more than $38 million in funding over the next four years to support clinical trials, natural history studies and regulatory science tools related to rare diseases....
Ricki Fairley, the founder and CEO of Touch, the Black Breast Cancer Alliance in Annapolis, discusses how she created a whole new life for herself after her breast cancer diagnosis and how her nonprofit aims to change the way the world looks at Black women...
The lasting impacts of the COVID-19 pandemic will be felt for decades to come, and some of those impacts aren’t fully understood yet, especially among communities of color and the elderly....
As part of its commitment to clinical research workforce development, ACRP is offering a new scholarship program to support clinical researchers on their pathway toward a master’s degree in clinical research....
Check out some photos from the inaugural Wisconsin Collaborative Clinical Research Professionals Conference at UW–Madison....
Michaele Linden-Johnson is at the helm of a program designed to better serve the health and clinical trial needs of her nearly 90% Hispanic patient population in and around El Paso, Texas....
